NCT07101718View on ClinicalTrials.gov

Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts

CompletedOBSERVATIONAL
Enrollment

25,419

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 10, 2024

Study Completion Date

December 31, 2024

Conditions
Liver Transplant
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

310006

Zhejiang University school of Medicine, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT07101718 - Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts | Biotech Hunter | Biotech Hunter